Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse.
作者信息
Hawkey C J
机构信息
Division of Gastroenterology, University Hospital, Nottingham.
出版信息
BMJ. 1994 Dec 10;309(6968):1570-1. doi: 10.1136/bmj.309.6968.1570.
Abstract
摘要
相似文献
1
Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse.根除幽门螺杆菌在消化性溃疡的治疗中应起关键作用。根除幽门螺杆菌在很大程度上可预防复发。
BMJ. 1994 Dec 10;309(6968):1570-1. doi: 10.1136/bmj.309.6968.1570.
2
Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Helicobacter pylori is not the causative agent.根除幽门螺杆菌在消化性溃疡的治疗中应起关键作用。幽门螺杆菌不是病原体。
BMJ. 1994 Dec 10;309(6968):1571-2. doi: 10.1136/bmj.309.6968.1571.
3
[Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].[通过根除幽门螺杆菌预防消化性溃疡出血复发]
Gastroenterol Hepatol. 2005 Nov;28(9):567-75. doi: 10.1157/13080605.
4
Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
Hepatogastroenterology. 1992 Feb;39 Suppl 1:40-4.
5
Peptic ulcer disease: what is the role for Helicobacter pylori?
Semin Gastrointest Dis. 1994 Jan;5(1):24-31.
6
Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.在评估幽门螺杆菌根除情况之前使用H2受体拮抗剂进行维持治疗可降低该菌成功根除后消化性溃疡的复发率：前瞻性随机对照试验。
J Gastroenterol Hepatol. 2006 Jun;21(6):1048-53. doi: 10.1111/j.1440-1746.2005.04038.x.
7
Helicobacter pylori and gastrointestinal disease.幽门螺杆菌与胃肠道疾病
J Clin Pharmacol. 1995 Jul;35(7):647-54. doi: 10.1002/j.1552-4604.1995.tb04103.x.
8
Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.幽门螺杆菌根除后消化性溃疡复发：一项5年随访研究。
Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S35-8.
9
Modern management of peptic ulcer.消化性溃疡的现代管理
Practitioner. 1992 Oct;236(1519):956-61.
10
[Peptic ulcer recurrent in patients following successful eradication of Helicobacter pylori].
Nihon Rinsho. 2005 Nov;63 Suppl 11:508-11.
引用本文的文献
1
Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.组胺H2受体拮抗剂维持治疗与幽门螺杆菌根除治疗的决策分析：十二指肠溃疡持续疼痛患者的一项随机对照试验
Pharmacoeconomics. 1999 Oct;16(4):355-65. doi: 10.2165/00019053-199916040-00004.
2
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.使用奥美拉唑联合克拉霉素或阿莫西林进行幽门螺杆菌根除治疗的决策分析。
Pharmacoeconomics. 1996 Jul;10(1):79-92. doi: 10.2165/00019053-199610010-00008.
3
Why is mortality higher in poorer areas and in more northern areas of England and Wales?为何在英格兰和威尔士较贫困地区以及更靠北的地区死亡率更高？
J Epidemiol Community Health. 1998 Jun;52(6):344-52. doi: 10.1136/jech.52.6.344.
4
Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.老年人消化性溃疡出血：幽门螺杆菌和非甾体抗炎药的相对作用
Gut. 1997 Oct;41(4):459-62. doi: 10.1136/gut.41.4.459.
5
Eradication of Helicobacter pylori in management of peptic ulceration. Evidence supports eradication only in patients who have helicobacter and peptic ulceration.根除幽门螺杆菌在消化性溃疡治疗中的应用。有证据表明，仅在患有幽门螺杆菌和消化性溃疡的患者中支持根除治疗。
BMJ. 1995 Feb 25;310(6978):531. doi: 10.1136/bmj.310.6978.531.
6
Eradication of Helicobacter pylori in management of peptic ulceration. Gastric metaplasia should be considered too.根除幽门螺杆菌在消化性溃疡治疗中的应用。胃化生也应予以考虑。
BMJ. 1995 Feb 25;310(6978):531. doi: 10.1136/bmj.310.6978.531a.
本文引用的文献
1
Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.消化性溃疡疾病的长期奥美拉唑治疗：胃泌素、内分泌细胞生长及胃炎
Gastroenterology. 1993 May;104(5):1356-70. doi: 10.1016/0016-5085(93)90344-c.
2
Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.雷尼替丁以及阿莫西林加甲硝唑对幽门螺杆菌根除及十二指肠溃疡复发的影响
N Engl J Med. 1993 Feb 4;328(5):308-12. doi: 10.1056/NEJM199302043280503.
3
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.幽门螺杆菌的治疗可降低消化性溃疡疾病的再出血率。
Scand J Gastroenterol. 1993 Nov;28(11):939-42. doi: 10.3109/00365529309098288.
4
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors.幽门螺杆菌阳性献血者中消化性溃疡的患病率。
Gut. 1994 Mar;35(3):309-12. doi: 10.1136/gut.35.3.309.
5
Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence.综述文章：对根除幽门螺杆菌及溃疡复发有积极影响的治疗方法。
Aliment Pharmacol Ther. 1994 Aug;8(4):359-68. doi: 10.1111/j.1365-2036.1994.tb00303.x.
6
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.通过根除幽门螺杆菌实现十二指肠溃疡愈合而无需抗酸治疗：随机对照试验
Lancet. 1994 Feb 26;343(8896):508-10. doi: 10.1016/s0140-6736(94)91460-5.
7
Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection.近期使用H2拮抗剂、抗生素以及胃部手术作为沙门氏菌感染的危险因素。
BMJ. 1994 Jan 15;308(6922):176. doi: 10.1136/bmj.308.6922.176.
8
Attempt to fulfil Koch's postulates for pyloric Campylobacter.尝试满足幽门弯曲菌的科赫法则。
Med J Aust. 1985 Apr 15;142(8):436-9. doi: 10.5694/j.1326-5377.1985.tb113443.x.
9
Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients.有或无慢性胃炎患者十二指肠和胃溃疡10年累积症状性风险。454例门诊患者的临床随访研究。
Scand J Gastroenterol. 1990 Oct;25(10):966-73. doi: 10.3109/00365529008997621.
10
Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study.幽门螺杆菌根除后胃炎的消失。一项形态计量学研究。
Scand J Gastroenterol. 1991 Oct;26(10):1057-65. doi: 10.3109/00365529109003956.
Zotero 插件